Hattersley Gary sold 100,000 shares of Nuvation Bio Inc. at $7.09 for −$709k on Aug 19, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
CHIEF SCIENTIFIC OFFICER
CHIEF SCIENTIFIC OFFICER
Filed Aug 21, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$709,240Shares × reported price
Shares traded
100,000Class A Common Stock
Price per share
$7.09Reported price. Read footnotes for ranges.
% of reported position traded
100%This security and ownership context
Holdings after
0Direct
Trade date
Aug 19, 2026Sell
Filed
Aug 21, 2026, 4:49 PM ET2-day reporting delay
Accession
0001521111-26-000005Code S · Transaction 30746
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 100,000 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 19, 2026Option exercise100,000$1.87$187,000Trade 30745
Aug 19, 2026Option exercise100,000$0.00$0Trade 30747
3 transaction rows in this filing. Joint filers share the same rows.

NUVB price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
NUVB · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −9.7%1w ago −7.4%1d ago +0.4%
Returns since7d −3.9%30d −16%90d180d1y

Footnotes in full

F1: Shares sold pursuant to a 10b5-1 plan dated December 4, 2025. F2: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.02 to $7.21. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3: Option vests as to 25% on the one year anniversary of February 29, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.